Advertisement

Familial Cancer

, Volume 12, Issue 4, pp 699–706 | Cite as

“High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis”

  • Yasser A. Alderlieste
  • Barbara A. Bastiaansen
  • Elisabeth M. H. Mathus-Vliegen
  • Dirk J. Gouma
  • Evelien Dekker
Original Article

Abstract

Advanced duodenal adenomatosis in patients with familial adenomatous polyposis (FAP) is associated with a significant risk of duodenal carcinoma. Duodenectomy is sometimes indicated to prevent malignant transformation or to resect established carcinomas. Advanced recurrent adenomatosis and cancer formation in the neo-duodenum after duodenectomy in FAP have been reported. The aim of this study was to describe findings during endoscopic follow-up in a cohort of FAP patients after duodenectomy, to assess the indication and whether recommendations can be made for endoscopic surveillance. All FAP patients with a history of duodenectomy performed at a single tertiary referral centre between January 2000 and July 2011 were identified. Patient characteristics and postoperative upper endoscopic procedures were reviewed retrospectively. 19 patients, with a mean age of 49 years at the time of duodenectomy were identified. One patient was lost to follow-up. The majority of patients underwent prophylactic pancreas preserving duodenectomy (95 %). Mean duration of postoperative follow-up in 18 patients was 78 months with 4 postoperative endoscopies on average. An increase in neo-Spigelman stage was seen in 9 patients, after an average interval of 35 months. Overall, newly formed adenomas in the neo-duodenum were found in 14 of 18 patients (78 %), after a mean of 46 months after duodenectomy. Recurrent adenomas were mostly located in close proximity to the neo-papilla. This included advanced adenomas in 7 patients, warranting enteric re-resection in 2 patients. Continued intensive endoscopic surveillance is indicated after duodenectomy in FAP, especially of the area around the bilio- and pancreatico-enteric anastomoses.

Keywords

Endoscopic surveillance Spigelman classification Neo-duodenum Familial adenomatous polyposis Duodenectomy 

Notes

Acknowledgments

We are grateful for the help of Dr. S. M. de Castro in updating the list of candidate patients in the current study.

Conflict of interest

None.

References

  1. 1.
    Ruo L, Coit DG, Brennan MF et al (2002) Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg 6(5):671–675PubMedCrossRefGoogle Scholar
  2. 2.
    Björk J, Akerbrant H, Iselius L et al (2001) Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 121(5):1127–1135PubMedCrossRefGoogle Scholar
  3. 3.
    Iaquinto G, Fornasarig M, Quaia M et al (2008) Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc 67(1):61–67PubMedCrossRefGoogle Scholar
  4. 4.
    Langers AM, De Vos tot Nederveen Cappel WH, Veenendaal RA et al (2008) Double balloon endoscopy for detection of small-bowel adenomas in familial adenomatous polyposis after pancreaticoduodenectomy according to Whipple. Endoscopy 40(9):773–774PubMedCrossRefGoogle Scholar
  5. 5.
    Latchford AR, Neale KF, Spigelman AD et al (2009) Features of duodenal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 7(6):659–663PubMedCrossRefGoogle Scholar
  6. 6.
    Monkemuller K, Fry LC, Ebert M et al (2007) Feasibility of double-balloon enteroscopy-assisted chromoendoscopy of the small bowel in patients with familial adenomatous polyposis. Endoscopy 39(1):52–57PubMedCrossRefGoogle Scholar
  7. 7.
    Bülow S, Björk J, Christensen IJ et al (2004) Duodenal adenomatosis in familial adenomatous polyposis. Gut 53(3):381–386PubMedCrossRefGoogle Scholar
  8. 8.
    Bülow S, Christensen IJ, Højen H et al (2011) Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 14(8):947–952CrossRefGoogle Scholar
  9. 9.
    Groves CJ, Saunders BP, Spigelman AD et al (2002) Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 50(5):636–641PubMedCrossRefGoogle Scholar
  10. 10.
    Schulmann K, Hollerbach S, Kraus K et al (2005) Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes. Am J Gastroenterol 100(1):27–37PubMedCrossRefGoogle Scholar
  11. 11.
    van Heumen BW, Nieuwenhuis MH, van Goor H et al (2012) Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study. Surgery 151(5):681–690PubMedCrossRefGoogle Scholar
  12. 12.
    de Vos tot Nederveen Cappel WH, Järvinen HJ et al (2003) Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 90(6):705–710PubMedCrossRefGoogle Scholar
  13. 13.
    de Castro SM, van Eijck CH, Rutten JP et al (2008) Pancreas-preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum. Br J Surg 95(11):1380–1386PubMedCrossRefGoogle Scholar
  14. 14.
    Gallagher MC, Shankar A, Groves CJ et al (2004) Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 91(9):1157–1164PubMedCrossRefGoogle Scholar
  15. 15.
    Caillié F, Paye F, Desaint B et al (2012) Severe duodenal involvement in familial adenomatous polyposis treated by pylorus-preserving Pancreaticoduodenectomy. Ann Surg Oncol 19(9):2924–2931PubMedCrossRefGoogle Scholar
  16. 16.
    Skipworth JR, Morkane C, Raptis DA et al (2011) Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis. HPB (Oxford) 13(5):342–349CrossRefGoogle Scholar
  17. 17.
    Lepistö A, Kiviluoto T, Halttunen J et al (2009) Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 41(6):504–509PubMedCrossRefGoogle Scholar
  18. 18.
    Mackey R, Walsh RM, Chung R et al (2005) Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J Gastrointest Surg 9(8):1088–1093PubMedCrossRefGoogle Scholar
  19. 19.
    Sarmiento JM, Thompson GB, Nagorney DM et al (2002) Pancreas-sparing duodenectomy for duodenal polyposis. Arch Surg 137(5):557–562PubMedCrossRefGoogle Scholar
  20. 20.
    Penninga L, Svendsen LB (2011) Pancreas-preserving total duodenectomy: a 10-year experience. J Hepatobiliary Pancreat Sci 18(5):717–723PubMedCrossRefGoogle Scholar
  21. 21.
    Kalady MF, Clary BM, Tyler DS et al (2002) Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 6(1):82–87PubMedCrossRefGoogle Scholar
  22. 22.
    Al-Sarireh B, Ghaneh P, Gardner-Thorpe J et al (2008) Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps. Br J Surg 95(12):1506–1511PubMedCrossRefGoogle Scholar
  23. 23.
    Alderlieste YA, Rauws EA, Mathus-Vliegen EM et al (2013) Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis. Fam Cancer Published Online First 12(1):51–56CrossRefGoogle Scholar
  24. 24.
    Spigelman AD, Granowska M, Phillips RK (1991) Duodeno-gastric reflux and gastric adenomas: a scintigraphic study in patients with familial adenomatous polyposis. J R Soc Med 84(8):476–478PubMedGoogle Scholar
  25. 25.
    Mabrut JY, Romagnoli R, Collard JM et al (2006) Familial adenomatous polyposis predisposes to pathologic exposure of the stomach to bilirubin. Surgery 40(5):818–823CrossRefGoogle Scholar
  26. 26.
    Chomchai C, Bhadrachari N, Nigro ND (1974) The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum 17(3):310–312PubMedCrossRefGoogle Scholar
  27. 27.
    Berkhout M, Roelofs HM, Friederich P et al (2007) Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study. Transl Res 150(3):147–149PubMedCrossRefGoogle Scholar
  28. 28.
    Tong JL, Ran ZH, Shen J et al (2008) Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies. Yonsei Med J 49(5):792–803PubMedCrossRefGoogle Scholar
  29. 29.
    Benetatos N, Ammori MB, Ammori BJ (2011) Laparoscopic pancreas-preserving total duodenectomy for familial adenomatous polyposis. Surg Laparosc Endosc Percutan Tech 21(6):e332–e335PubMedCrossRefGoogle Scholar
  30. 30.
    Vasen H, Möslein G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57(5):704–713PubMedCrossRefGoogle Scholar
  31. 31.
    Balmforth DC, Phillips RK, Clark SK (2012) Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy? Fam Cancer 11(4):553–557PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Yasser A. Alderlieste
    • 1
  • Barbara A. Bastiaansen
    • 1
  • Elisabeth M. H. Mathus-Vliegen
    • 1
  • Dirk J. Gouma
    • 2
  • Evelien Dekker
    • 1
  1. 1.Department of Gastroenterology and Hepatology, Academic Medical CentreUniversity of AmsterdamAmsterdamThe Netherlands
  2. 2.Department of Surgery, Academic Medical CentreUniversity of AmsterdamAmsterdamThe Netherlands

Personalised recommendations